Dan Elbaum

Company: QurAlis Corp.

Job title: Chief Scientific Officer

Seminars:

Next Generation Splice Modulation Platform: Balancing Activity, Safety & Distribution of ASOs 3:40 pm

Contextualizing preRNA mis-splicing as a recurring theme in neurodegenerative diseases Highlighting QurAlis’ FlexASO™ platform that enables the design and synthesis of splice-switching ASOs with enhanced potency, safety, and biodistribution properties Discussing the platform generally and in the context of QurAlis’ discovery programsRead more

day: Day One Mid Day